GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan
1. GSK boosted long-term revenue outlook to over £40 billion by 2031. 2. A $2.5 billion stock buyback was announced, signaling confidence. 3. Fourth-quarter EPS and revenue surpassed estimates, showing strong performance. 4. Revenue growth for 2025 expected at 3%-5% despite vaccine declines.